December 20th 2024
Jason M Pogue, PharmD, BCPS, BCIDP discusses the findings, pharmacokinetics, why ceftolozane-tazobactam may be the preferred choice for resistant infections, and more.
November 11th 2024
Fluoroquinolone Antibiotics: More Recommendations for Prudent Use
October 29th 2018Despite concerning findings and warnings, fluoroquinolones have remained one of the world’s most commonly prescribed antibiotic classes, with the United States accounting for more than 32 million prescriptions in 2015 alone.
Read More
New Alternative to Injectable Antibiotics May be Key to Treating Neonatal Sepsis
October 26th 2018Building on decades-old research, scientists in France say they’ve developed an effective rectal delivery formulation of an antibiotic used to save infants with life-threatening neonatal sepsis.
Read More
Investigators in Japan Find Benefits of Earlier Antibiotic Stewardship Intervention
October 26th 2018A new study by investigators in Japan finds that earlier antibiotic stewardship intervention decreased antibiotic usage and costs and were associated with reduced rates of antibiotic resistance.
Read More
Intravenous Fosfomycin In Development for United States
October 25th 2018Because of the recent concern in the United States around the rise of resistant pathogens, intravenous fosfomycin has gained renewed interest because of its activity and demonstrated synergy with other classes of antibiotics.
Read More
Accelerate Pheno Blood Culture Detection System Found to Shorten Blood Analysis Time
October 23rd 2018Use of the FDA–cleared Accelerate Pheno blood culture detection system can shorten the time required to analyze patients’ blood samples leading to improved clinical outcomes, according to the results of a recent study.
Read More